Advances in the development of entry inhibitors for sialic-acid-targeting viruses
Over the past decades, several antiviral drugs have been developed to treat a range of infections. Yet the number of treatable viral infections is still limited, and resistance to current drug regimens is an ever-growing problem. Therefore, additional strategies are needed to provide a rapid cure fo...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15367
- Acceso en línea:
- https://doi.org/10.1016/j.drudis.2020.10.009
http://hdl.handle.net/20.500.12010/15367
- Palabra clave:
- Viral infection
Antiviral drugs
Viral entry
Sialic acids
Entry inhibitors
Broadspectrum antiviral drugs
Multivalency
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)